uridine triphosphate has been researched along with Atherogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KC; Eun, SY; Kim, HJ; Lee, JH; Park, SW | 1 |
1 other study(ies) available for uridine triphosphate and Atherogenesis
| Article | Year |
|---|---|
P2Y(2)R activation by nucleotides released from oxLDL-treated endothelial cells (ECs) mediates the interaction between ECs and immune cells through RAGE expression and reactive oxygen species production.
Topics: Adenosine Triphosphate; Atherosclerosis; Cell Line; Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Molecular Targeted Therapy; Oxidative Stress; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Purinergic P2Y; Uridine Triphosphate; Vascular Cell Adhesion Molecule-1 | 2014 |